Treatment of refractory ascites;Traitement de l'ascite réfractaire

Gastroenterologie Clinique et Biologique

Volumn 28, Issue SPEC. ISS. 2, 2004, Pages

  Pomier Layrargues, Gilles ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ASCITES; CONFERENCE PAPER; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PARACENTESIS; PORTOCAVAL SHUNT; PORTOSYSTEMIC ANASTOMOSIS; THERAPY RESISTANCE; TREATMENT INDICATION;

ALGORITHMS; ASCITES; HUMANS; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PUNCTURES;

EID: 2442448550     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (33)

1. Schrier RW. Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J. Peripheral arterial vasodilatation hypothesis: a proposal for initiation of renal and sodium retention in cirrhosis. Hepatology 1988;8:1151-7.
2. Arroyo V, Gines P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996;23:164-76.
3. Guardiola J, Baliellas C, Xiol X, Fernandez Esparrach G, Gines P, Ventura P, et al. External validation of a prognostic model for predicting survival of cirrhotic patients with refractory ascites. Am J Gastroenterol 2002;97:2374-8.
4. Gines P, Arroyo V, Quintero E, Planas R, Bory F, Cabrera J, et al. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Gastroenterology 1987;93:234-41.
5. Gines P, Tito LL, Arroyo V, Planas R, Panes J, Viver J, et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology 1988;94:1493-502.
6. Gines A, Fernandez-Esparrach G, Monescillo A, Vila C, Dumenech E, Abecassis R, et al. Randomized trial comparing albumin, dextran 70 and polygeline in cirrhotic patients treatd by paracentesis. Gastroenterology 1996;111:1002-10.
7. Le Veen HH, Christoudias G, Moon IP, Luft R, Falk G, Gorsberg S. Peritoneo-venous shunting for ascites. Ann Surg 1974;180:590-1.
8. Wapnick S, Grosberg SJ, Evans MI. Randomized prospective matched pair study comparing peritoneo-venous shunt and conventional therapy in massive ascites. Br J Surg 1979;66:667-70.
9. Bories P, Garcia-Compean D, Michel H, Bourel M, Capron JP, Gauthier A, et al. The treatment of refractory ascites by the Le Veen shunt: a multicenter controlled trial (57 patients). J Hepatol 1986;3:212-8.
10. Stanley MM, Ochi S, Lee KL, Nemchansky BA, Greenlee HB, Allen JL, et al. Peritoneo-venous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. N Engl J Med 1989;321:1632-8.
11. Gines P, Arroyo V, Vargas V, Planas R, Casafont F, Panes J, et al. Paracentesis with intravenous infusion of albumin and compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med 1991;325:829-35.
12. Gines A, Planas R, Angeli P, Guarner C, Salemo F, Gines P, et al. Treatment of patients with cirrhosis and refractory ascites by Leveen shunt with titanium tip. Comparison with therapeutic paracentesis. Hepatology 1995;22:124-31.
13. Welch HF, Welch CS, Carter JH. Prognosis after surgical treatment of ascites. Results of side-to-side shunt in 40 patients. Surgery 1964;56:75-82.
14. Burchell AR, Rousselot LM, Panke WF. A seven year experience with side-to-side portacaval shunt for cirrhotic ascites. Ann Surg 1968;168; 655-70.
15. Franco D, Vons C, Traynor O, Smajda C. Should portosystemic shunt be reconsidered in the treatment of intractable ascites in cirrhosis. Arch Surg 1988;123:987-91.
16. Ferral HJ, Bjarnason H, Wegryn SA, Rengel GJ, Nazarian GK, Rank JM, et al. Refractory ascites: early experience in treatment with transjugular intrahepatic portosystemic shunt. Radiology 1993;189:795-801.
17. Ochs A, Rossle M, Haag K, Hauenstein KH, Deibert P, Siegerstetter V, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995;332:1193-7.
18. Quiroga J, Sangro B, Nunez M, Bilbao I, Longo J, Garcia-Villareal L, et al. Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral and hemodynamic parameters. Hepatology 1995;21:986-94.
19. Somberg KA, Lake JR, Tomlanovich J, Laberge JM, Feldstein V. Bass N. Transjugular intrahepatic porto-systemic shunts for refractory ascites : assessment of clinical and hormonal response and renal function. Hepatology 1995;21:709-16.
20. Wong F, Sniderman K, Liu P, Allidina Y, Sherman M, Blendis L. Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites. Ann Intern Med 1995;122:816-22.
21. Forrest EH, Stanley AJ, Redhead DN, McGilchrist AJ, Hayes PC. Clinical response after transjugular intrahepatic portosystemic stent shunt insertion for refractory ascites in cirrhosis. Aliment Pharmacol Ther 1996;10:801-6.
22. Martinet JP, Legault L, Cernacek P, Roy L, Dufresne MP, Spahr L, et al. Changes in plasma endothelin-1 and Big endothelin-1 induced by transjugular intrahepatic shunt in cirrhotic patients with refractory ascites. J Hepatol 1996;25:700-6.
23. Martinet JP, Legault L, Roy L, Fenyves D, Dufresne MP, Spahr L, et al, Treatment of refractory ascites using transjugular intrahepatic portosystemic shunt (TIPS): a caution. Dig Dis Sci 1997;42:161-6.
24. Deschênes M, Dufresne MP, Bui B, Fenyves D, Spahr L, Roy L, et al. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites. Am J Gastroenterol 1999;94:1361-5.
25. Lebrec D, Giuily N, Hadengue A, Vilgrain V, Moreau R, Poynard T, et al. Transjugular intrahepatic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. J Hepatol 1996;25:135-44.
26. Rossle M, Ochs A, Gülberg V, Siegerstetter V, Holl J, Delpert P, et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 2000;342:1701-7.
27. Sanyal AJ, Genning C, Reddy R, Wong F, Knowdley KV, Benner K, et al. The North American study for the treatment of refractory ascites. Gastroenterology 2003;124:634-41.
28. Gines P, Uriz J, Calahorra B, Garcia-Tsao G, Kamath PS, Ruiz Del Arbol L, Planas R, et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 2002;123:1839-47.
29. Cesna M, Peck-Radosavljevic M, Thurnher SA, Hittmair K, Shoder M, Lammer J. Creation of transjugular intrahepatic portosystemic shunt with stent grafts: initial experiences with a polytetrafluoroethylene-covered initial endoprothesis. Radiology 2001;221:437-46.
30. Bureau C, Garcia-Pagan JC, Pomier-Layrargues G, Otal P, Chabbert C, Cortez P, et al. The use of polytetrafluoroethylene (PTFE)-covered stents improves the patency of TIPS: results of a randomized study (abstract). Hepatology 2002;36:294A.
31. Duvoux C, Zanditenas D, Hezode C, Chauvat A, Monin JL, Roudot-Thoraval F, et al. Effects of nor-adrenalin and albumin in patients with type 1 hepatorenal syndrome. A pilot study. Hepatology 2002;36:374-80.
32. Gerbes AL, Gulberg V, Gines P, Decaux G, Gross P, Gandjini H, et al. Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial. Gastroenterology 2003;124:933-9.
33. Allard JP, Chan J, Sandokji K, Blendis LM, Wong F. Effects of ascites resolution after successful TIPS on nutrition in cirrhotic patients with refractory ascites. Am J Gastroenterol 2001;96:2442-7.